What you need to know about pancreatic cancer
Key takeaways:
- Experts do not recommend pancreatic cancer screening for people at average risk because the disease is rare and current screening methods are not accurate enough for widespread use.
- People at high risk for pancreatic cancer, including those with certain inherited genetic mutations, hereditary pancreatitis or a strong family history of the disease, may be eligible for screening through specialized medical centers.
- Promising research in 2026 showed the targeted therapy daraxonrasib nearly doubled the overall survival rate for patients with previously treated metastatic pancreatic cancer.
We at the Prevent Cancer Foundation are committed to advancing cancer prevention and the use of proven routine screening methods and tools. We also recognize that for most cancer types, there are no recommended routine screenings currently available.
While we work to close this gap, we’re giving you the facts on cancers without recommended routine screening options. Our goal is to create as much awareness as possible about risk factors, symptoms and innovations so you can advocate for your health.
Learn about the research the Prevent Cancer Foundation is funding to close the screening gap.
Pancreatic cancer is one of the deadliest cancers, largely because it is often found after it has already spread—it accounts for roughly 8% of all cancer deaths in the United States, despite accounting for only 3% of all cancer diagnoses.
Unlike Brust, cervical oder colorectal cancers, there is no routine screening test for people at average risk of pancreatic cancer. But researchers are making exciting progress in detecting the disease earlier and developing more effective treatments.
Understanding your risk and knowing if or when to talk with your health care provider can help you make informed decisions about your health.
Who is at risk of developing pancreatic cancer?
Anyone can develop pancreatic cancer, but some people are at increased risk compared to others.
You are at increased risk for pancreatic cancer if you:
- Are 65 or older.
- Use tobacco products, including cigarettes, or have used them in the past.
- Are overweight or medically classified as obese.
- Have Type 2 diabetes, especially if it developed later in life.
- Have chronic pancreatitis (long-term inflammation of the pancreas).
- Have a personal or Familiengeschichte of pancreatic cancer.
- Have certain inherited genetic mutations.
- Drink alcohol heavily, which can contribute to chronic pancreatitis.
It’s important to understand that most people who have one or more of these risk factors will not develop pancreatic cancer. Likewise, some people diagnosed with pancreatic cancer have no known risk factors. But being aware of how these factors impact your risk is an important step in taking charge of your health.
For people of average risk, why is there no routine screening for pancreatic cancer?
Experts do not currently recommend pancreatic cancer screening for people at average risk. There are a few reasons for this, including:
- Pancreatic cancer is relatively rare.
- The pancreas is located deep inside the body, making tumors difficult to detect by scans.
- Current blood tests and imaging are not accurate enough for screening everyone at average risk and could lead to unnecessary procedures or false-positive results.
Although there is no current recommended screening tests, researchers are studying new blood tests, artificial intelligence (AI) tools, and imaging technologies that may one day enable routine pancreatic cancer screening for early detection.
Can people at a high risk of pancreatic cancer get screened?
Yes—people who are at high risk for pancreatic cancer may be able to access screenings.
If you have two or more first-degree relatives (parent, child or sibling) or certain inherited genetic mutations, you may benefit from pancreatic cancer screening at a specialized medical center and/or under the care of a genetic counselor.
You may qualify for screening if you:
- Have two or more close relatives (parent, child or sibling) who has had pancreatic cancer.
- Have an inherited genetic mutation, such as a mutation to the BRCA1, BRCA2, PALB2, CDKN2A, STK11, ATM, TP53, or Lynch syndrome-associated genes.
- Have hereditary pancreatitis.
LESEN SIE AUCH | Understanding Lynch syndrome: The genetic link to colorectal cancer
Screening for people at increased risk usually involves invasive tests performed at regular intervals, such as:
- Magnetic resonance imaging (MRI)
- Magnetic resonance cholangiopancreatography (MRCP), a type of MRI that produces detailed pictures of the pancreas
- Endoscopic ultrasound (EUS), a combination of an endoscopy and an ultrasound that looks at your upper digestive tract.
Those at increased or moderate risk are not recommended for routine surveillance. This cohort is managed by monitoring underlying conditions and evaluation if clinical red flags or symptoms arise. Moderate risk includes those with:
- Chronic pancreatitis
- Fettleibigkeit
- Rauchen
- New onset diabetes
- Single distant or older-onset family member without a known genetic mutation
Screening is generally recommended only after meeting with a genetic counselor and then discussing the benefits and limitations with a pancreatic oncologist. If pancreatic cancer is present in your family health history, ask your health care provider whether genetic testing is appropriate.
Are there signs or symptoms of pancreatic cancer?
Early-stage pancreatic cancer often has no symptoms, and that is what makes it so tricky to catch before it grows and/or spreads to other parts of the body. As the disease progresses, symptoms may include:
- Yellowing of the skin or eyes (jaundice)
- Dark urine or light-colored stools
- Pain in the upper abdomen or back
- Unexplained weight loss
- Appetitverlust
- Indigestion
- Abdominal bloating
- Nausea
- Ermüdung
- New-onset diabetes after age 50
- Blood clots
These symptoms are more commonly caused by conditions other than pancreatic cancer. But if unusual symptoms persist or are unexplained, it’s important to see a health care provider.
What is the link between pancreatic cancer and my genetics or family health history?
About one in 10 pancreatic cancers are linked to inherited genetic factors. Having a parent, child or sibling with pancreatic cancer increases your risk, particularly if multiple family members have been affected.
LESEN SIE AUCH | I have a family history of cancer. When should I get screened?
Genetic testing may identify inherited mutations that increase the risk of pancreatic cancer and several other cancers, including breast, ovarian and colorectal cancers. Knowing this information can help guide cancer screening for you and sometimes for your relatives. A genetic counselor can help determine whether testing is right for you.
LESEN SIE AUCH | What do you do if you don’t know your family medical history?
Are there ways to prevent pancreatic cancer or reduce my risk?
There is no guaranteed way to prevent pancreatic cancer, but you can lower your risk by:
- Not using tobacco products, including cigarettes. If you do smoke, it is never too late to quit. Call 1-800-QUIT-NOW for help.
- Maintaining a healthy weight.
- Being physically active. Aim for at least 30 minutes of physical activity at least five days a week.
- Eating a diet rich in fruits, vegetables and whole grains.
- Limiting alcohol. It’s best to avoid alcohol completely, but if you do choose to drink, limit your drinking to no more than one drink a day if you were assigned female at birth, and no more than two drinks a day if you were assigned male at birth.
- Managing diabetes and other chronic health conditions.
- Talking with your health care provider about your family health history.
What’s new in pancreatic cancer research?
Researchers are making important progress in detection and treatment of pancreatic cancer.
A new promising development in research includes targeted therapies for tumors with specific genetic mutations. In June 2026, landmark findings from a clinical trial showed the oral targeted drug daraxonrasib nearly doubled overall survival in patients who had previously been treated for metastatic pancreatic cancer (pancreatic cancer that had spread to other parts of the body). The patient survival rate was 13.2 months, compared to 6.7 months for those who received standard-of-care chemotherapy.
Additional promising areas of research include:
- Blood-based tests that can detect tumor DNA, proteins and other biomarkers before symptoms develop.
- AI tools that analyze medical records, blood tests and imaging to identify people at increased risk.
- Precision medicine, which matches treatments to specific genetic changes in a person’s tumor.
- Personalized vaccines and immunotherapies, which are being evaluated in clinical trials.
- Expanded tumor profiling, which may help more patients identify treatment options and inform family members about inherited cancer risk.
While these advances are encouraging, most are still being studied and are not yet recommended for routine screening of the average-risk public.
The bottom line
There is currently no routine screening test for pancreatic cancer for people at average risk. But, knowing your family health history, understanding your personal risk factors, and maintaining healthy lifestyle habits can help you take charge of your health.
If pancreatic cancer runs in your family or you are concerned about inherited risk, talk with your health care provider about genetic counseling and whether you may benefit from a high-risk surveillance program. Researchers continue to make progress toward detecting pancreatic cancer earlier and providing more personalized treatments, bringing hope for better outcomes in the future.